Suppr超能文献

血管紧张素 II 受体阻滞剂缬沙坦降低原发性高血压患者的 QTc 离散度可能与其抗氧化应激作用有关。

Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.

作者信息

Miyajima Katsuaki, Minatoguchi Shinya, Ito Yoko, Hukunishi Masanori, Matsuno Yasunari, Kakami Masao, Kawasaki Masanori, Nishigaki Kazuhiko, Takemura Genzou, Fujiwara Hisayoshi

机构信息

Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.

出版信息

Hypertens Res. 2007 Apr;30(4):307-13. doi: 10.1291/hypres.30.307.

Abstract

QT dispersion has been reported to increase in patients with essential hypertension, and abnormal QT dispersion is associated with arrythmias and sudden cardiac death. However, whether change in QT dispersion is related to oxidative stress is unclear. We examined the effect of the angiotensin II receptor blocker valsartan on QT dispersion and the relationship between oxidative stress and QT dispersion in patients with essential hypertension. Hypertensive patients whose systolic blood pressure (SBP) was more than 140 mmHg and/or diastolic blood pressure (DBP) was more than 90 mmHg were treated with valsartan. Blood pressure was measured once a month for 6 months. The difference between the maximal and minimal QT intervals within a 12-lead surface ECG was measured and QT dispersion and QTc dispersion corrected by heart rate were obtained before and 6 months after treatment. Left ventricular mass (LVM) assessed by echocardiography was obtained at baseline and 6 months after treatment. Venous blood samples were obtained at baseline and 6 months after treatment to measure serum levels of lipoperoxidation (LPO) and type I and III procollagen. Treatment with valsartan significantly decreased SBP and DBP. QTc dispersion decreased significantly 6 months after treatment with valsartan as compared to the baseline values. Valsartan treatment did not affect the LVM. Valsartan significantly decreased the abnormally high LPO levels. The changes in QTc dispersion were positively correlated with changes in the serum levels of LPO and with changes in DBP. The correlation between changes in LPO and QTc dispersion was more close than that between changes in DBP and QTc dispersion. In conclusion, antihypertensive therapy with valsartan reduces QTc dispersion and this may be related to the ability of valsartan to reduce oxidative stress in patients with essential hypertension.

摘要

据报道,原发性高血压患者的QT离散度会增加,且异常的QT离散度与心律失常和心源性猝死有关。然而,QT离散度的变化是否与氧化应激有关尚不清楚。我们研究了血管紧张素II受体阻滞剂缬沙坦对原发性高血压患者QT离散度的影响以及氧化应激与QT离散度之间的关系。收缩压(SBP)大于140 mmHg和/或舒张压(DBP)大于90 mmHg的高血压患者接受缬沙坦治疗。每月测量一次血压,共测量6个月。测量12导联体表心电图中最大和最小QT间期的差值,计算治疗前和治疗6个月后的QT离散度和经心率校正的QTc离散度。通过超声心动图评估的左心室质量(LVM)在基线和治疗6个月后获取。在基线和治疗6个月后采集静脉血样本,测量血清脂质过氧化(LPO)水平以及I型和III型前胶原水平。缬沙坦治疗可显著降低SBP和DBP。与基线值相比,缬沙坦治疗6个月后QTc离散度显著降低。缬沙坦治疗对LVM无影响。缬沙坦可显著降低异常升高的LPO水平。QTc离散度的变化与血清LPO水平的变化以及DBP的变化呈正相关。LPO变化与QTc离散度之间的相关性比DBP变化与QTc离散度之间的相关性更密切。总之,缬沙坦抗高血压治疗可降低QTc离散度,这可能与缬沙坦降低原发性高血压患者氧化应激的能力有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验